Cancer trials suspended for new patients
Beth Israel Deaconess Medical Center temporarily closed all its cancer trials to new patients last week, after audits found that several researchers had not properly submitted patient data to the committee that oversees oncology research and to trial sponsors.
“Some of our clinical trials were not running with the high standards that we expect,’’ Randy Mason, vice president of research operations, wrote in an e-mail to hospital executives and physician leaders last week.
He described the lapses as involving documentation and reporting compliance and said the hospital has not found any “issues of patient harm.’’
- CVS Ramps Up Retail Clinics with Provider Affiliations
- 4 Tectonic Shifts Shaking Up Healthcare
- Contradictory Obamacare Rulings Issued by Appellate Courts
- As States Regulate Provider Competition, Common Threads Emerge
- As HIPAA Breaches Accelerate, Tools Lag
- Medical Errors Third Leading Cause of Death, Senators Told
- Study Puts Spotlight on Preventing Fall-Related Injuries
- Wanted: Nurse PhDs
- Roundtable: Life After a Healthcare Organization Acquisition
- Drug Pricing 'Tantamount to Greed,' Lawmaker Says